]PYY at a dose of each that differentiated between the two behaviors. Some differences were seen in the distribution of Fos-IR produced by the two peptides. Overall, however, the patterns of expression were similar. Our behavioral and anatomic results suggest that NPY-containing pathways controlling estrous and feeding behavior innervate similar nuclei, with the divergence in pathways controlling the separate behaviors characterized by linkage to different NPY receptor subtypes. lordosis; Y2 receptor; Y5 receptor; c-Fos; peptide YY LIMITED FOOD AVAILABILITY diminishes fertility in all mammals, particularly female mammals (4). Nutritional infertility is characterized by multiple effects on reproductive physiology and behavior, including suppression of estrous behaviors (for review, see Ref. 46). Female Syrian hamsters provide a useful model for the study of nutritional infertility. Nutritional challenges that put hamsters in a negative energy balance suppress ovulatory cycles and estrous behavior (46). In hamsters and rats, information about nutritional status is communicated to forebrain circuits controlling gonadotropin-releasing hormone (GnRH) and reproductive behaviors via detectors for metabolic fuel availability located in the viscera and caudal hindbrain (26, 32) . However, very little is known about the mechanisms by which information regarding energy balance is transmitted from the hindbrain and visceral detectors to the forebrain effector circuits. One possible mediator is neuropeptide Y (NPY).
tide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters. Am J Physiol Regulatory Integrative Comp Physiol 280: R1061-R1068, 2001.-Central injections of neuropeptide Y (NPY) increase food intake in Syrian hamsters; however, the effect of NPY on sexual behavior in hamsters is not known nor are the receptor subtypes involved in feeding and sexual behaviors. We demonstrate that NPY inhibits lordosis duration in a dose-related fashion after lateral ventricular injection in ovariectomized, steroid-primed Syrian hamsters. Under the same conditions, we compared the effect of two receptor-differentiating agonists derived from peptide YY (PYY), PYY- and [Leu 31 ,Pro 34 ]PYY, on lordosis duration and food intake. PYY-(3-36) produced a 91% reduction in lordosis duration at 0.24 nmol. [Leu 31 ,Pro 34 ]PYY was less potent, producing a reduction in lordosis duration (66%) only at 2.4 nmol. These results suggest NPY effects on estrous behavior are principally mediated by Y2 receptors. PYY- and [Leu 31 ,Pro 34 ]PYY stimulated comparable dose-related increases in total food intake (2 h), suggesting Y5 receptors are involved in feeding. The significance of different NPY receptor subtypes controlling estrous and feeding behavior is highlighted by results on expression of Fos immunoreactivity (Fos-IR) elicited by either PYY- or [Leu 31 ,Pro 34 ]PYY at a dose of each that differentiated between the two behaviors. Some differences were seen in the distribution of Fos-IR produced by the two peptides. Overall, however, the patterns of expression were similar. Our behavioral and anatomic results suggest that NPY-containing pathways controlling estrous and feeding behavior innervate similar nuclei, with the divergence in pathways controlling the separate behaviors characterized by linkage to different NPY receptor subtypes. lordosis; Y2 receptor; Y5 receptor; c-Fos; peptide YY LIMITED FOOD AVAILABILITY diminishes fertility in all mammals, particularly female mammals (4) . Nutritional infertility is characterized by multiple effects on reproductive physiology and behavior, including suppression of estrous behaviors (for review, see Ref. 46 ). Female Syrian hamsters provide a useful model for the study of nutritional infertility. Nutritional challenges that put hamsters in a negative energy balance suppress ovulatory cycles and estrous behavior (46) . In hamsters and rats, information about nutritional status is communicated to forebrain circuits controlling gonadotropin-releasing hormone (GnRH) and reproductive behaviors via detectors for metabolic fuel availability located in the viscera and caudal hindbrain (26, 32) . However, very little is known about the mechanisms by which information regarding energy balance is transmitted from the hindbrain and visceral detectors to the forebrain effector circuits. One possible mediator is neuropeptide Y (NPY).
NPY is 36-amino acid member of the pancreatic polypeptide (PP), or PP-fold, family of peptides, which includes PYY (42, 43) . NPY is highly conserved throughout evolution and found in abundance in the brain of humans and a number of rodent species, including Syrian hamsters (Mesocricetus auratus) (1, 27, 30, 37) . Of the six NPY receptor subtypes characterized (31), three subtypes, Y1, Y2, and Y5, are implicated in behavioral function (10, 13, 38) , display a distinct pharmacology (2, 47) , and have been cloned (13, 24, 36) .
Converging evidence suggests NPY may have a functional role in nutritional infertility. Central injections of NPY stimulate robust and long-lasting increases in food intake in rats and hamsters (5, 22, 39) and also suppress reproductive behavior in rats (6, 34) . Moreover in rats, NPY synthesis in the hypothalamus appears to be regulated by nutritional status. That is, gene expression and NPY levels increase in response to food restriction or fasting (3, 7) . These observations suggest that fluctuations in NPY synthesis and release, controlled by an animal's energy balance, have a dual effector role in the control of appetite and reproduction. That is, increased NPY synthesis and release at targets in the central nervous system (CNS) result in increased appetite and metabolic efficiency during periods of reduced access to adequate nutrition, whereas at the same time blunting reproductive function, including estrous behavior (21) . Thus NPY may be a key neurotransmitter in the neural circuitry involved in nutritional infertility.
In the study reported here, we found that central administration of NPY reduced estrous behavior, as measured by lordosis duration, in ovariectomized (OVX), steroid-primed female Syrian hamsters. In addition, we determined the effect of two NPY receptor agonists, [Leu 31 ,Pro 34 ]PYY and PYY-(3-36), on lordosis duration and food intake. Agonists were chosen based on their differential interaction with NPY receptor subtypes (9) and because they are known to have powerful effects on behavior in other rodent species (13) . PYY-(3-36) binds with high affinity to both Y2 and Y5 receptors, but exhibits intermediate to low affinity for Y1 receptors (2, 13, 17) . [Leu 31 , Pro   34 ]PYY, in contrast, binds with high affinity to Y1 as well as Y5 receptors but is highly selective against Y2 receptors (9) . In addition to behavioral studies, to assess differences between neural pathways involved in estrous and feeding behavior, we also examined the effect of [Leu 31 , Pro 34 ]PYY and PYY-(3-36) on expression of the c-Fos-IR in forebrain loci that contain estrogen receptors and are implicated in control of reproductive function or food intake.
MATERIALS AND METHODS

Animals and Housing Conditions
Female Lak:LVG Syrian hamsters (Charles River Breeding Laboratories, Wilmington, MA), weighing between 110 and 154 g at the time of testing, were singly housed in stainless steel, wire-bottom cages on a 14:10-h light-dark cycle (lights on at 6:00 AM). Ambient temperature was maintained at 22 Ϯ 2°C. Purina laboratory rodent chow (5001) was available ad libitum, except where indicated. Water was available at all times.
Surgery
After acclimation to the laboratory for 1 wk, hamsters were bilaterally OVX under pentobarbital sodium anesthesia (80 mg/kg ip). One week after OVX, each hamster was reanesthetized and stereotaxically implanted with a 22-gauge, stainless-steel guide cannula (Plastics One, Roanoke, VA) aimed at the lateral ventricle (1.1 mm posterior to bregma, lateral 1.7 mm, and subdural 2.2 mm). Guide cannulas were held in place with dental acrylic bonded to stainless steel screws anchored to the skull. An obturator was inserted into each guide cannula and remained in place, flush with the tip of the guide cannula, except during injections. Animals were given at least 1 wk to recover from stereotaxic surgery before the start of behavioral testing. During that time they were handled and mock injected to facilitate adaptation to the intracerebroventricular injection procedure.
Behavioral Experiments
Forty-eight hours before each behavioral test, hamsters were injected subcutaneously with 5.0 g of estradiol benzoate (EB) followed 44 h later with 500 g of progesterone (P). Intracerebroventricular injections were made 20-50 min before the start of lordosis testing. Briefly, this procedure involved intracerebroventricular injections made by replacing the obturator with an injector that extended 1.0 mm beyond the tip of the guide cannula. Each injector was connected by saline-filled PE tubing to a microliter syringe controlled by an infusion pump (Stoetling model 53220, Wood Dale, IL). A small air bubble separated saline in the PE tubing from intracerebroventricular solutions. The volume of all intracerebroventricular infusions was 5 l, delivered over a 1-min period. Testing of lordosis duration was initiated 6 h after injection of P by placing each hamster in a Plexiglas arena in the presence of a male hamster. The total number of seconds spent by the female in the lordosis posture during a 3-min test was recorded. To elicit lordosis, a consistent level of stimulation was applied to each female's flank region throughout the test period using strokes of a soft 1-cm artist's paintbrush (45) .
In experiment 1 (n ϭ 16), the effect of NPY on duration of lordosis was tested using two doses of NPY, administered intracerebroventricularly, each dose given in crossover design with vehicle. To verify cannula placement, hamsters were deeply anesthetized at the end of the experiment and given an intracerebroventricular injection of india ink using infusion conditions identical to those used in peptide tests. Animals were immediately killed, and brains were removed and sectioned to analyze the distribution of ink.
In experiment 2 (n ϭ 20), the dose effect of two receptor differentiating NPY agonist analogs, PYY-(3-36) and [Leu 31 ,Pro 34 ]PYY, on lordosis duration and food intake was examined and compared using a two-group design, one peptide per group, with dose as a repeated variable in each group. Half the hamsters in each group received doses in an ascending order, starting with vehicle, half in descending order, ending with vehicle. Food intake was measured in addition to estrous behavior by removing food at the time of the intracerebroventricular injections and placing a preweighed pellet of chow in each cage. Intake, corrected for spillage, was measured 1 and 2 h after the infusion. Cheek pouches were checked at the beginning of the experiment and at each time point. Pouching was rare and treated as spillage. Hamsters were removed from their home cages for ϳ8 min for testing of estrous behavior; hence, during this period in the first hour after intracerebroventricular injection they did not have access to the food pellet.
c-Fos Immunocytochemistry
In experiment 3, forebrains of hamsters that were used in experiment 2 (n ϭ 19) were analyzed for Fos-IR 2 wk after completion of behavioral testing. Hamsters were steroid primed, as in experiments 1 and 2, and randomly assigned to receive intracerebroventricular administration of either 0.72 nmol PYY-(3-36), 0.72 nmol [Leu 31 ,Pro 34 ]PYY, or vehicle. Loci chosen for analysis have been shown to be rich in estrogen receptors and express Fos-IR when animals were made sexually receptive by treatment with EB and P (12, 33) . Some of these regions are also NPY sensitive and implicated in control of food intake (25) . Fos-IR cell counts were made in the anterior parvocellular paraventricular nucleus of the hypothalamus (aPVN), the suprachiasmatic nucleus (SCN), medial preoptic area (mPOA), ventral lateral septum, including the septohypothalamic nucleus (VLS), ventromedial hypothalamic nucleus including the ventrolateral portion (VMH), arcuate nucleus (Arc), the dorsoposterior principal nucleus of the bed nucleus of the stria terminalis (BNST), and dorsomedial amygdala (mAMY).
For both peptides, a dose 0.72 nmol was given because this dose was optimal for eliciting the differential behavioral effects produced by the two peptides. That is, 0.72 nmol of [Leu 31 ,Pro 34 ]PYY was effective in stimulating food intake but did not affect lordosis, whereas 0.72 nmol PYY-(3-36) completely inhibited lordosis but had no significant effect on 1-or 2-h food intake. Hamsters were randomly assigned to receive either vehicle or the peptide that they received in experiment 2. Food was removed at the time of the intracerebroventricular injection. One hour after intracerebroventricular injection, hamsters were deeply anesthetized with pentobarbital sodium, injected with 5,000 U heparin, and perfused intracardially with 0.9% saline for 30 s followed by 2% acrolein infusion for 15 min. Brains were removed, blocked, and immersed overnight in phosphate-buffered 20% sucrose. The following morning, coronal 40-m sections were cut on a freezing rotary microtome, beginning in the medial preoptic area and extending to the caudal ventromedial nucleus of the hypothalamus. Cut sections were stored in cryoprotectant until the start of the Fos immunostaining procedure.
After removal from cryoprotectant, every fourth section was taken in series, rinsed thoroughly in 0.05 M Tris-buffered saline (TBS; pH 7.6), and processed in 1% sodium borohydride for 10 min followed by thorough rinsing in 0.05 M TBS. To reduce nonspecific staining, tissue was incubated for 20 min in 20% goat antirabbit serum in 0.05 M TBS (including 1% H 2 O 2 and 1.0% BSA). Sections were then incubated in anti-c-Fos-selective antiserum, Ab-5 (1:100,000; Oncogene Research Products, Cambridge, MA), in 1% goat serum and 0.05 M TBS (including 0.52% Triton X-100, 1.0% gelatin, and 0.02% sodium azide) for 72 h at 4°C. After incubation, sections were rinsed in 0.05 M TBS buffer (pH 7.6; including 0.02% Triton X-100, 1.0% gelatin, and 0.02% sodium azide) followed by a 90-min incubation in 3 g/ml biotinylated goat antirabbit IgG (Vector, Burlingame, CA). After two 5-min rinses in 0.05 TBS (with 0.02 Triton X-100, 1.0% gelatin and 0.02% sodium azide) and a single 5-min rinse in 0.05 M TBS, sections were incubated in 1:100 dilution of Vector ABC Elite Kit (Burlingame, CA). Sections were then rinsed in three 5-min rinses of 0.05M TBS. Finally, sections were placed in 0.05% diaminobenzidine tetrahydrochloride (DAB) in 0.05 M TBS, including 0.05% hydrogen peroxide for, ϳ5 min and then rinsed three times in 0.05% TBS.
Loci targeted for analysis were matched for each animal. Fos-IR was visualized using a light microscope and digitized using image analysis software (National Institutes of Health Image 1.61). Cell counting was done using the same software. Threshold parameters for target size and density were derived using the program, and criteria were consistently applied to all sections in each locus measured. Experimenters who were blind to treatment conditions carried out matching and measurements.
Peptides, Drugs, and Reagents
Human/rat NPY, human [Leu 31 ,Pro 34 ]PYY, and human des(Tyr-Pro)PYY [PYY-(3-36)] were purchased from Peninsula Laboratories. Peptides were dissolved in a vehicle of artificial cerebrospinal fluid (aCSF) from Harvard Apparatus (Holliston, MA), which served as the control injection. EB and P were dissolved in a vehicle of sesame oil. Steroids, sesame oil, and all other reagents were purchased from Sigma Chemical.
Statistical Analysis
Peptide effects on lordosis duration for the first test were compared using two-way ANOVA. Because baseline food intake for the two peptide treatment groups differed significantly (Student's t-test, P Ͻ 0.01), a two-way ANOVA was used to compare peptide effects on 2-h food intake with food intake after vehicle treatment subtracted for each animal. Dose response analyses were performed using 1-way ANOVA, with dose as the repeated measure. Significant ANOVA results at ␣ ϭ 0.05 were followed by pairwise comparisons using Dunnett's multiple comparisons test or Student-Newman-Keuls test. Paired t-tests were used where indicated.
RESULTS
Experiment 1
Effect of NPY on lordosis duration. NPY produced significant 33 and 67% reductions in lordosis duration at 0.24 and 2.4 nmol, respectively (Fig. 1) . Analysis of india ink distribution revealed widespread distribution in the lateral ventricle injection site, third ventricle, contralateral lateral ventricle, and cerebral aqueduct in all hamsters.
Experiment 2
Effect of PYY- (Fig. 2) .
The effect of PYY-(3-36) on lordosis appeared to be reversible but long lasting (Fig. 3) . PYY-(3-36) continued to suppress lordosis 4 h after the initial test 31 ,Pro 34 ]PYY on food intake. [Leu 31 ,Pro 34 ]PYY and PYY-(3-36) produced dose-related stimulations of food intake 1 (analysis not shown) and 2 after intracerebroventricular injection [F(3,30) ϭ 14.14, P Ͻ 0.0001 and F (3, 24) ϭ9.84, P ϭ 0.002, respectively (Fig. 4) ]. The two peptides did not differ in their capacity to stimulate food intake at either time point.
Effect of PYY-(3-36) and [Leu
Experiment 3
Effect of PYY- 3 . Dose-response effect of intracerebroventricular PYY-(3-36) (n ϭ 9) and LP PYY (n ϭ 11) on lordosis duration at 3 and 2 time points, respectively, after administration of peptides. Dunnett's test: *P Ͻ 0.05 vs. 0.00 dose at the same time point. Fig. 4 . Dose-response effect of intracerebroventricular PYY-(3-36) (n ϭ 9) and LP PYY (n ϭ 11) on 1-and 2-h cumulative food intake in ad libitum-fed OVX hamsters pretreated with EB and P. Data are reported as grams ingested (means Ϯ SE) above aCSF controls, because 0.00 intakes for the two groups differed significantly at both 1-and 2-h time points, unpaired t-tests: P Ͻ 0.01. Absolute baseline intakes: PYY-(3-36) ϭ 1 h, 0.27 Ϯ 0.07 and 2 h, 0.37 Ϯ 0.05; LP PYY ϭ 1 h, 0.53 Ϯ 0.08 and 2 h, 0.81 Ϯ 0.13. Dunnett's test: **P Ͻ 0.01, *P Ͻ 0.05 vs. 0.00. and exhibits low to intermediate affinity for Y1 receptors (2, 13, 17, 47) . PYY-(3-36) acted with 10-fold greater potency, based on the lowest dose eliciting a threshold effect, was more efficacious in the dose range tested, and had a longer duration of action than [Leu 31 , Pro   34 ]PYY, an agonist that binds preferentially to Y1 and Y5 receptors but is inactive on Y2 receptors (2, 13, 24) . Because [Leu 31 ,Pro 34 ]PYY and PYY-(3-36) exhibit comparable affinity for Y5 receptors (13), the relative differences in potency and efficacy between these two agonists favor the hypothesis that estrous behavior is principally inhibited through activation of Y2 receptors in Syrian hamsters. [Leu 31 , Pro   34 ]PYY does not bind to Y2 receptors (11, 14, 16) ; therefore, the modest inhibition of estrous behavior produced by the highest dose of [Leu 31 ,Pro 34 ]PYY suggests that another NPY receptor subtype, perhaps Y1, may also link to neural pathways that inhibit estrous behavior. Conclusions regarding receptor subtype involvement are made cautiously given that only two receptor-differentiating ligands were tested, and both are agonists at more than one NPY receptor subtype. Moreover, although NPY binding sites are abundant in Syrian hamster brain (29) , the pharmacology of NPY receptor binding sites in this species has not been explored. In this regard it is noteworthy, however, that Y1, Y2, and Y5 receptor mRNAs are present in hamster brain (S. Chua, personal communication).
The large difference in potency and efficacy between [Leu 31 ,Pro 34 ]PYY and PYY- in the inhibition estrous behavior was not characteristic of their effects on food intake. The two peptides produced compar- in stimulating food intake in the current experiment is a very close match to their relative potency to activate Y5 receptors in biochemical experiments (13) . Our results, therefore, favor the hypothesis that the effect of NPY on feeding in Syrian hamsters is mediated by Y5 receptors. As is the case with estrous behavior, other alternatives are possible, including an action at multiple or novel receptors. Our results are comparable to those obtained in rats using similar agonists (13, 40) .
A dual behavioral effect of NPY, inhibition of estrous behavior, and stimulation of feeding was first demonstrated in female rats (6) . The present results, taken together with previous reports (22) , argue that NPY has a similar function in Syrian hamsters. Moreover, the current results suggest that NPY's effects on feeding and estrous behavior are mediated by separate and independent receptors.
Immunocytochemical detection of the protein product of the immediate early gene c-fos has served as a marker of neural activation in a number of studies examining effects of either NPY or steroid hormones (12, 23, 25, 33, 48) . To illuminate the neural circuitry controlling inhibition of estrous behavior and stimulation of feeding, we compared Fos-IR expression after administration of an intermediate dose of each peptide. PYY-(3-36) was tested at a dose that almost totally suppressed estrous behavior but did not significantly increase food intake, whereas [Leu 31 ,Pro 34 ]PYY was tested at a dose that stimulated food intake at 1 and 2 h but did not inhibit estrous behavior.
We observed widespread distribution of Fos-IR expression in OVX hamsters primed with EB and P. Peptide treatments influenced Fos-IR in four of eight loci examined, and in three of those four loci, PYY- 34 ]PYY affect behaviors through signaling pathways that activate Fos-IR, our results are consistent with the notion that NPY control of estrous and feeding behavior involves neural circuits that innervate several of the same nuclei including the aPVN, mPOA, and SCN. Whether these pathways overlap at any level remains to be determined. Of course, other interpretations of the data are plausible.
It should be noted that peptide effects on Fos-IR might be unrelated to the function of these peptides in feeding or estrous behavior. In fact, NPY and its analogs are known to affect neuroendocrine functions, including timing of the circadian clock in the SCN (15, 18) and GnRH activity in the mPOA (20, 35, 44) .
Our results are consistent with previous studies showing that NPY potently induces Fos-IR in the PVN of rats (23, 25, 48) . Changes in Fos-IR, however, were not seen in all regions important in feeding (3, 41) or neuroendocrine function (12, 33) . Neither peptide affected Fos-IR expression in the BNST and mAMY, nor in the Arc or VMH, where NPY has been shown to stimulate moderate increases in Fos-IR in rats (25) .
Support for NPY's physiological role in the control of feeding and reproductive behavior remains to be established in hamsters. Pharmacological evidence from rats, however, argues persuasively that NPY plays a physiological role in these behaviors. Central administration of NPY antibodies, for example, suppresses 24-h food intake (8) and attenuates 2-deoxy-D-glucoseinduced hyperphagia (19) in rats. NPY antibody infu- sion also increases sexual receptivity and reduces food intake and body weight gain in genetically obese and infertile Zucker rats (28) .
Perspectives
Limited food availability increases hunger and diminishes fertility in mammals (4) . Little is known about the neurotransmitters controlling nutritional infertility; however, the close relationship between fertility and nutrient status suggests neurotransmitters important in control of feeding may also be involved in the control of reproductive function. NPY fits this model. It has been proposed that NPY plays a dual role in motivation, decreasing sexual drive while increasing drive to secure adequate nutrient energy (21) . The brain is enriched in NPY afferents to sites such as the aPVN, which has a well-characterized role as a target of NPY in the control of food intake (39) . The large effect of PYY-(3-36) on stimulation of Fos-IR expression in the aPVN and inhibition of lordosis raises the suggestion that NPY may act on targets in the aPVN to control reproductive behavior. When access to adequate nutrition is restricted, activity may increase in NPY pathways integrating nutritional status. The present results suggest that divergence between the neural circuits controlling feeding and reproduction may be through pathways expressing differing NPY receptor subtypes, Y2 for estrous behavior, and Y5 for feeding behavior.
